10-Q Filing

CVS HEALTH CORP CIK: 64803 Q3 2019

Filing Information

Form Type	10-Q
Accession Number	`0000064803-19-000049`
Period End Date	20190930
Filing Date	20191106
Fiscal Year	2019
Fiscal Period	Q3
XBRL Instance	a0930201910-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 104 Income Statement 113 Cash Flow Statement 94 Stockholders Equity 80 Comprehensive Income 36

Balance Sheet 104 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.19B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.06B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$2.33B	USD	Point-in-time
Investments	`ShortTermInvestments`	$2.52B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$19.79B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$17.63B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Inventories	`InventoryNet`	$16.45B	USD	Point-in-time
Inventories	`InventoryNet`	$16.03B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.73B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.72B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.58B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.84B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$48.19B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.30B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.29B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$45.24B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$17.34B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	424.00M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	425.00M	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$15.73B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.35B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.65B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.76B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Goodwill	`Goodwill`	$78.68B	USD	Point-in-time
Goodwill	`Goodwill`	$79.55B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$33.66B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$36.52B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$4.59B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$3.88B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.05B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.38B	USD	Point-in-time
Total assets	`Assets`	$220.11B	USD	Point-in-time
Total assets	`Assets`	$196.46B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$8.93B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$9.44B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$13.10B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$11.37B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$6.15B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$7.01B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$2.94B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$2.94B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$10.71B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$11.62B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.79B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.94B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.80B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$720.00M	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$1.07B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.78B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$1.26B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$52.54B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$44.01B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.83B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$64.21B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$71.44B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$7.68B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$7.28B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.88B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.59B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$8.12B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$7.56B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.18B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.78B	USD	Point-in-time
Total liabilities	`Liabilities`	$157.18B	USD	Point-in-time
Total liabilities	`Liabilities`	$137.91B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,725 shares issued and 1,301 shares outstanding at September 30, 2019 and 1,720 shares issued and 1,295 shares outstanding at December 31, 2018 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$45.85B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,725 shares issued and 1,301 shares outstanding at September 30, 2019 and 1,720 shares issued and 1,295 shares outstanding at December 31, 2018 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$45.44B	USD	Point-in-time
Treasury stock, at cost: 424 shares at September 30, 2019 and 425 shares at December 31, 2018	`TreasuryStockValue`	$28.21B	USD	Point-in-time
Treasury stock, at cost: 424 shares at September 30, 2019 and 425 shares at December 31, 2018	`TreasuryStockValue`	$28.23B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$44.02B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$40.91B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$950.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$102.00M	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$62.61B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$58.23B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$318.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$319.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$35.61B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.60B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$38.68B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$62.93B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.70B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.62B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$196.46B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$220.11B	USD	Point-in-time

Income Statement 113 line items

Line Item	Tag	Value	Unit	Period
Revenues from customers	`RevenueFromContractWithCustomerExcludingAssessedTax`	$64.55B	USD	1 Quarter
Revenues from customers	`RevenueFromContractWithCustomerExcludingAssessedTax`	$47.27B	USD	1 Quarter
Revenues from customers	`RevenueFromContractWithCustomerExcludingAssessedTax`	$139.67B	USD	3 Qtrs
Revenues from customers	`RevenueFromContractWithCustomerExcludingAssessedTax`	$189.08B	USD	3 Qtrs
Net investment income	`NetInvestmentIncome`	$221.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$805.00M	USD	3 Qtrs
Net investment income	`NetInvestmentIncome`	$485.00M	USD	3 Qtrs
Net investment income	`NetInvestmentIncome`	$263.00M	USD	1 Quarter
Total revenues	`Revenues`	$64.81B	USD	1 Quarter
Total revenues	`Revenues`	$47.49B	USD	1 Quarter
Total revenues	`Revenues`	$189.89B	USD	3 Qtrs
Total revenues	`Revenues`	$140.16B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$115.88B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$116.65B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$39.50B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$40.44B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$12.85B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$2.40B	USD	3 Qtrs
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$39.40B	USD	3 Qtrs
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$439.00M	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	$3.92B	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$14.76B	USD	3 Qtrs
Operating expenses	`OperatingExpenses`	$8.60B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$24.89B	USD	3 Qtrs
Operating expenses	`OperatingExpenses`	$4.97B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$44.92B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$180.94B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$61.88B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$136.96B	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$2.57B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$3.20B	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$2.93B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$8.95B	USD	3 Qtrs
Interest expense	`InterestExpense`	$2.30B	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.89B	USD	3 Qtrs
Interest expense	`InterestExpense`	$674.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$747.00M	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	Point-in-time
Other expense (income)	`OtherNonoperatingIncomeExpense`	$31.00M	USD	1 Quarter
Other expense (income)	`OtherNonoperatingIncomeExpense`	$-1.00M	USD	1 Quarter
Other expense (income)	`OtherNonoperatingIncomeExpense`	$93.00M	USD	3 Qtrs
Other expense (income)	`OtherNonoperatingIncomeExpense`	$-7.00M	USD	3 Qtrs
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.90B	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.13B	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.30B	USD	3 Qtrs
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$6.66B	USD	3 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$604.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$1.48B	USD	3 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$1.78B	USD	3 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$509.00M	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$1.39B	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-174.00M	USD	3 Qtrs
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$4.89B	USD	3 Qtrs
Loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	1 Quarter
Loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	3 Qtrs
Loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	1 Quarter
Loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.00M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-175.00M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$1.53B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$4.89B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$1.39B	USD	1 Quarter
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.00M	USD	1 Quarter
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$1.39B	USD	1 Quarter
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$-175.00M	USD	3 Qtrs
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$4.89B	USD	3 Qtrs
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$1.53B	USD	1 Quarter
Income (loss) from continuing operations attributable to CVS Health, basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.36	USD	1 Quarter
Income (loss) from continuing operations attributable to CVS Health, basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.17	USD	1 Quarter
Income (loss) from continuing operations attributable to CVS Health, basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$3.76	USD	3 Qtrs
Income (loss) from continuing operations attributable to CVS Health, basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.17	USD	3 Qtrs
Loss from discontinued operations attributable to CVS Health, basic (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	1 Quarter
Loss from discontinued operations attributable to CVS Health, basic (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	3 Qtrs
Loss from discontinued operations attributable to CVS Health, basic (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	3 Qtrs
Loss from discontinued operations attributable to CVS Health, basic (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	1 Quarter
Net income (loss) attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$1.36	USD	1 Quarter
Net income (loss) attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$3.76	USD	3 Qtrs
Net income (loss) attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.17	USD	3 Qtrs
Net income (loss) attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$1.17	USD	1 Quarter
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.02B	shares	3 Qtrs
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.30B	shares	1 Quarter
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.30B	shares	3 Qtrs
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.02B	shares	1 Quarter
Income (loss) from continuing operations attributable to CVS Health, diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.17	USD	3 Qtrs
Income (loss) from continuing operations attributable to CVS Health, diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.17	USD	1 Quarter
Income (loss) from continuing operations attributable to CVS Health, diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.36	USD	1 Quarter
Income (loss) from continuing operations attributable to CVS Health, diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$3.75	USD	3 Qtrs
Loss from discontinued operations attributable to CVS Health, diluted (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Loss from discontinued operations attributable to CVS Health, diluted (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Loss from discontinued operations attributable to CVS Health, diluted (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	3 Qtrs
Loss from discontinued operations attributable to CVS Health, diluted (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	3 Qtrs
Net income (loss) attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.36	USD	1 Quarter
Net income (loss) attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.75	USD	3 Qtrs
Net income (loss) attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.17	USD	1 Quarter
Net income (loss) attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.17	USD	3 Qtrs
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.30B	shares	3 Qtrs
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.02B	shares	3 Qtrs
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.02B	shares	1 Quarter
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.30B	shares	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.50	USD	3 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.50	USD	3 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter

Cash Flow Statement 94 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$132.28B	USD	3 Qtrs
Cash receipts from customers	`ProceedsFromCustomers`	$184.52B	USD	3 Qtrs
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$107.92B	USD	3 Qtrs
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$109.96B	USD	3 Qtrs
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$2.40B	USD	3 Qtrs
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$38.81B	USD	3 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$21.41B	USD	3 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$12.30B	USD	3 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$406.00M	USD	3 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$756.00M	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$1.76B	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$2.67B	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$2.21B	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$1.91B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$6.39B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$10.21B	USD	3 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$5.62B	USD	3 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$43.00M	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$6.01B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$97.00M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.45B	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.89B	USD	3 Qtrs
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$361.00M	USD	3 Qtrs
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$616.00M	USD	3 Qtrs
Proceeds from sale of subsidiary	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	-	USD	3 Qtrs
Proceeds from sale of subsidiary	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$725.00M	USD	3 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-11.00M	USD	3 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-16.00M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.39B	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.63B	USD	3 Qtrs
Net borrowings (repayments) of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$-1.28B	USD	3 Qtrs
Net borrowings (repayments) of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$350.00M	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$39.38B	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$3.46B	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$8.35B	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$2.27B	USD	3 Qtrs
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	$-446.00M	USD	3 Qtrs
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	$25.00M	USD	Point-in-time
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	$25.00M	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.53B	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.95B	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$183.00M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$214.00M	USD	3 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$85.00M	USD	3 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$39.00M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$11.00M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$34.93B	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.41B	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$39.93B	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.17B	USD	3 Qtrs
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$41.83B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.47B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.90B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.29B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$41.83B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.47B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.90B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.29B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$-175.00M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$1.53B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$4.89B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$1.39B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.27B	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.91B	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	$3.92B	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$172.00M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$355.00M	USD	3 Qtrs
Loss on sale of subsidiary	`DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax`	$86.00M	USD	3 Qtrs
Loss on sale of subsidiary	`DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax`	$205.00M	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	Point-in-time
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$210.00M	USD	3 Qtrs
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$-38.00M	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$2.31B	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$1.73B	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-472.00M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-413.00M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$3.00M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$374.00M	USD	3 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$1.84B	USD	3 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$2.33B	USD	3 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$535.00M	USD	3 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	-	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$859.00M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-322.00M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$6.39B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$10.21B	USD	3 Qtrs

Stockholders Equity 80 line items

Line Item	Tag	Value	Unit	Period
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$31.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$31.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$31.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Adoption of new accounting standard	`CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption`	$-13.00M	USD	Point-in-time
Decrease to accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$950.00M	USD	Point-in-time
Decrease to accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$102.00M	USD	Point-in-time
Increase to retained earnings	`RetainedEarningsAccumulatedDeficit`	$44.02B	USD	Point-in-time
Increase to retained earnings	`RetainedEarningsAccumulatedDeficit`	$40.91B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$35.61B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.60B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$38.68B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$62.93B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.70B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.62B	USD	Point-in-time
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$998.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$1.43B	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$1.39B	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$1.93B	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$1.53B	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-2.56B	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$266.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$331.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$301.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$251.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$848.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-31.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-12.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$344.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$96.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$135.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$112.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$104.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$175.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$73.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$-50.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$36.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$33.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$-49.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$-7.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$-49.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$512.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$651.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$508.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$659.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$649.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$512.00M	USD	1 Quarter
Other (decreases) increases in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$-4.00M	USD	1 Quarter
Other (decreases) increases in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$3.00M	USD	1 Quarter
Other (decreases) increases in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$2.00M	USD	1 Quarter
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$35.61B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.60B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$38.68B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$62.93B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.70B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.62B	USD	Point-in-time

Comprehensive Income 36 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-175.00M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$1.53B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$4.89B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$1.39B	USD	1 Quarter
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$721.00M	USD	3 Qtrs
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$136.00M	USD	1 Quarter
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$157.00M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-8.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$153.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-34.00M	USD	3 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-23.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$335.00M	USD	3 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-4.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-30.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$266.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$331.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$301.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$251.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$848.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-31.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-12.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$344.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.38B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.74B	USD	3 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$126.00M	USD	3 Qtrs
Comprehensive loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.00M	USD	1 Quarter
Comprehensive loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Comprehensive loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Comprehensive loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.38B	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$126.00M	USD	3 Qtrs
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.80B	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$5.74B	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.